Donald Furman M.D.
Co-Founder and Chief Development Officer, Alignment Healthcare
Donald Furman M.D. is the Chief Development Officer of Alignment Healthcare LLC, a health care services company focused on providing population health management services to health systems and provider groups around the country. Before joining Alignment Healthcare LLC, Dr. Furman was the Senior Director of Healthcare Services in the Health and Life Sciences division of Oliver Wyman from 2012 to 2013. At Oliver Wyman, Dr. Furman worked with teams that devised and helped deploy population health models for health plans, medical groups, and hospital systems. From 2010-2012 Dr. Furman was an independent consultant to hospital systems, health plans, and medical groups envisioning and deploying population care models and telemedicine systems. Dr. Furman practiced Internal Medicine and Gastroenterology in Orange County, CA from 1981-1997. In 1993 he was one of the founders of CareMore Medical Group, CareMore IPA and CareMore Medical Enterprises. CareMore took full risk for a Medicare HMO product and partial risk for commercial products. Dr. Furman became Chief Medical officer for the CareMore entities and Vice Chairman of the board of the CareMore Board of Directors. During his tenure Dr. Furman and his colleagues developed the CareMore clinical care model, which led to transformational improvement in clinical outcomes and industry leading decreases in costs, resulting in a higher level of patient satisfaction. In 2006 Dr. Furman and his partners sold the CareMore entities to John Kao and his team supported by CCMP capital. Dr. Furman stayed on as Chief Medical Officer and then Chief Medical Advisor until 2010. Dr. Furman received a Bachelor of Science degree from The American University in Washington D.C. He received his M.D. from Wayne State University in Detroit. He trained in Internal Medicine and Gastroenterology at Yale University in New Haven and is boarded in both specialties. He received an M.B.A. from University of California, Irvine in 1998.